U.S. Markets closed

The Zacks Analyst Blog Highlights: Wells Fargo, Danaher, Colgate-Palmolive, STERIS and Aetna

Zacks Equity Research

For Immediate Release

Chicago, IL – December 30, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Wells Fargo (NYSE:WFC –Free Report),Danaher (NYSE:DHR –Free Report),Colgate-Palmolive (NYSE:CL – Free Report), STERIS (NYSE:STE –Free Report) and Aetna (NYSE:AET – Free Report).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Thursday’s Analyst Blog:

Top Research Reports for Friday: WFC, DHR, CL

Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo (NYSE:WFC –Free Report), Danaher (NYSE:DHR –Free Report) and Colgate-Palmolive (NYSE:CL – Free Report).

Shares of Buy rated Wells Fargo have gained 1.8% year to date, underperforming the Zacks Banks - Major Regional sector which has gained 21.4% over the same period. Wells Fargo has long maintained a reputation for disciplined and reliable operations and an attractive retail banking franchise. Regrettably, the sales practices controversy has taken center stage and cost the well regarded CEO his position.

However, the new management team is making all the right moves and further downside risks in the stock are low at this stage. Though it will likely take a while for clouds to fully lifted, continued growth in loans and deposits and expansion moves should support its growth profile (You can read the full research report on Wells Fargo here . )

Danaher shares have declined 15.9% year to date, underperforming the Zacks Diversified Operations sector, which has gained 7.8% over the same period. Its shares have struggled lately on concerns about its business repositioning that involved greater exposure to the healthcare and environmental verticals following the Fortive spin-off. The analyst points out that the new Danaher is less exposed to volatile end-markets following the spin-off and has a more recurring revenue business.

On the flip side, sluggish economic conditions across some key operating regions and unfavorable currency translations pose as significant headwinds. (You can read the full research report on Danaher here.)

Colgate-Palmolive shares have slipped 1.5% year to date, underperforming the Zacks Soap and Cleaning Materials sector, which has gained 1.4% over the same period. The analyst likes its product innovation, globally recognized brands and presence in both developed and emerging economies. The company anticipates delivering robust organic sales growth, backed by new products across categories and geographical regions.

However, as the company derives 75% of its revenues from operations outside the U.S., it expects macroeconomic headwinds and currency woes to linger and weigh on its top and bottom lines in 2016. (You can read the full research report on Colgate-Palmolive here.)

Other noteworthy reports we are featuring today include STERIS (NYSE:STE –Free Report) and Aetna (NYSE:AET – Free Report).

Today's Private Buys & Sells from Zacks Research
While we share the above news with the public, our sensitive recommendations are hidden from everyone but selected members. Would you like to peek behind the curtain and view them?

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on WFC - FREE

Get the full Report on DHR - FREE

Get the full Report on CL - FREE

Get the full Report on STE - FREE

Get the full Report on AET - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.

This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
WELLS FARGO-NEW (WFC): Free Stock Analysis Report
 
DANAHER CORP (DHR): Free Stock Analysis Report
 
COLGATE PALMOLI (CL): Free Stock Analysis Report
 
STERIS PLC (STE): Free Stock Analysis Report
 
AETNA INC-NEW (AET): Free Stock Analysis Report
 
To read this article on Zacks.com click here.